Nabil F. Saba

Saba is an elected member of the American Head and Neck Society (AHNS) and also specializes in immunotherapy for head and neck cancer, and T cell and B cell activation related to HPV-positive disease.
Saba’s work focused on translational research and the study and development of novel therapeutic agents and modalities in the head, neck, and esophageal cancer. He led several clinical trials and chaired national and investigator-initiated multi-institution studies focused on novel approaches for treating these diseases. He is also the editor of two published textbooks, ''Sinonasal and Skull Base Malignancies'' and ''Esophageal Cancer, prevention, diagnosis, and therapy''. Provided by Wikipedia
Showing 1 - 20 results of 38 for search 'Nabil F. Saba', query time: 0.08s
Refine Results
-
1
The diverse functions of FAT1 in cancer progression: good, bad, or ugly? by Zhuo Georgia Chen, Nabil F. Saba, Yong Teng
Published 2022-08-01
Article -
2
Cancer metabolism and carcinogenesis by Jianqiang Yang, Chloe Shay, Nabil F. Saba, Yong Teng
Published 2024-01-01
Article -
3
RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies by Anja van de Stolpe, Wim Verhaegh, Jean-Yves Blay, Jean-Yves Blay, Cynthia X. Ma, Patrick Pauwels, Mark Pegram, Hans Prenen, Dirk De Ruysscher, Nabil F. Saba, Nabil F. Saba, Nabil F. Saba, Susan F. Slovin, Karen Willard-Gallo, Hatim Husain
Published 2021-02-01
Article -
4
Tumor secretome shapes the immune landscape during cancer progression by Jianqiang Yang, Sijia Tang, Nabil F. Saba, Chloe Shay, Yong Teng
Published 2025-02-01
Article -
5
-
6
-
7
Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States by Fan Yang, Chloe Shay, Marin Abousaud, Chris Tang, Yamin Li, Zhaohui Qin, Nabil F. Saba, Yong Teng
Published 2023-01-01
Article -
8
-
9
-
10
-
11
434 Investigating the metabolic-inflammatory mechanisms of cachexia symptoms in head and neck cancer patient plasma via multiomics integration of the metabolome, lipidome, and infl... by Ronald C. Eldridge, Nabil F. Saba, Andrew H. Miller, Evanthia C. Wommack, Jennifer Felger, Deborah W. Bruner, Canhua Xiao
Published 2024-04-01
Article -
12
-
13
-
14
Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab by Xuefeng Wang, Tingyi Li, Robbert J. C. Slebos, Ritu Chaudhary, Jose A. Guevara-Patino, Marcelo Bonomi, Nabil F. Saba, Christine H. Chung
Published 2025-03-01
Article -
15
-
16
-
17
Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck by Prashant Puttagunta, Saagar V. Pamulapati, James E. Bates, Jennifer H. Gross, William A. Stokes, Nicole C. Schmitt, Conor Steuer, Yong Teng, Nabil F. Saba
Published 2023-12-01
Article -
18
Statin Drugs Are Associated With Response to Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer by Tyler J. Kristoff, Sean Evans, Pranay Nayi, Marin Abousaud, Subir Goyal, Yuan Liu, Dong Shin, Conor E. Steuer, Nabil F. Saba, Nicole C. Schmitt
Published 2025-03-01
Article -
19
Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population––A SEER‐based analysis from 2000 to 2016 by Melissa A. Taylor, Jeffery Switchenko, William Stokes, Mihir R. Patel, Mark McDonald, Conor Steuer, Ashley Aiken, Jonathan J. Beitler, Dong M. Shin, Nabil F. Saba
Published 2021-09-01
Article -
20
Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma. by Sreenivas Nannapaneni, Christopher C Griffith, Kelly R Magliocca, Wanqi Chen, Xueying Lyu, Zhengjia Chen, Dongsheng Wang, Xu Wang, Dong M Shin, Zhuo G Chen, Nabil F Saba
Published 2021-01-01
Article